← Product Code [NEU](/submissions/SU/subpart-e%E2%80%94surgical-devices/NEU) · K111895 # ECHOTIP(R) ULTRA FIDUCIAL NEEDLE (K111895) _Wilson-Cook Medical Inc./Cook Endoscopy · NEU · Apr 27, 2012 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/NEU/K111895 ## Device Facts - **Applicant:** Wilson-Cook Medical Inc./Cook Endoscopy - **Product Code:** [NEU](/submissions/SU/subpart-e%E2%80%94surgical-devices/NEU.md) - **Decision Date:** Apr 27, 2012 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4300 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery ## Indications for Use This device is intended to implant fiducials under endoscopic ultrasound to radiographically mark soft tissue for future therapeutic procedures. ## Device Story EchoTip Ultra Fiducial Needle is a delivery system comprising a needle, sheath, handle, and stylet; preloaded with four pure gold fiducials. Needle features dimpled surface for enhanced echogenicity under endoscopic ultrasound guidance. User targets soft tissue; advances stylet to deploy fiducials. Once deployed, fiducials serve as permanent radiopaque reference points for future therapeutic procedures. Used in clinical settings by physicians; provides visual markers for subsequent interventions. Benefits include precise localization of soft tissue targets for therapy. ## Clinical Evidence Bench testing only. Included biocompatibility testing (cytotoxicity, irritation, sensitization, implantation) and chemical characterization. Simulated use testing confirmed effective deployment, fiducial visibility under ultrasound and radiographic imaging, and MR Conditional status per ASTM F2503-08. ## Technological Characteristics Delivery system includes needle, sheath, handle, and stylet. Four pure gold fiducials preloaded in laser-cut track. Needle is dimpled for echogenicity. MR Conditional per ASTM F2503-08. No electronic or software components. ## Regulatory Identification An implantable clip is a clip-like device intended to connect internal tissues to aid healing. It is not absorbable. ## Predicate Devices - BiomarC® Preloaded Tissue Marker Device ([K042296](/device/K042296.md)) - EchoTip® Ultra Ultrasound Needle ([K083330](/device/K083330.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ KIII895 Submitted By: Marge Walls-Walker, Senior Regulatory Specialist: Engineering Wilson-Cook Medical, Inc./Cook Endoscopy 4900 Bethania Station Road (336) 744-0157 June 30, 2011 510(k) SUMMARY Name of Device | Trade Name: | EchoTip ® Ultra Fiducial Needle | |----------------------------------|--------------------------------------------| | Common/Usual Name: | Implantable clip | | Proposed Classification Name(s): | Marker, Radiographic, Implantable | | | 21CFR 878.4300, NEU, Class II, and | | | Kit, Needle, Biopsy | | | 21 CFR 876.1075, FCG, Class II. | #### Predicate Devices BiomarC® Preloaded Tissue Marker Device, 510(k) No. K042296, cleared September 20, 2004 EchoTip® Ultra Ultrasound Needle, 510(k) No. K083330, cleared February 6, 2009 Intended Use This device is intended to implant fiducials under endoscopic ultrasound to radiographically mark soft tissue for future therapeutic procedures. ## Device Description The EchoTip® Ultra Fiducial Needle is composed of a delivery system (i.e., needle, sheath, handle, and stylet) with four pure gold fiducials preloaded and secured within a laser-cut track in the needle. The needle is dimpled to enhance its echogenicity, allowing the user to target tissues using endoscopic ultrasound guidance. The needle stylet is advanced to deploy the fiducials. Once deployed, the fiducials are permanent implants that serve as radiopaque reference points for future therapeutic procedures. #### Substantial Equivalence The EchoTip® Ultra Fiducial Needle is substantially equivalent to the Biomarce Preloaded Tissue Marker Device (510(k) No. K042296). Both devices are composed of fiducials (i.e., tissue markers) preloaded within a delivery system. Once deployed, the radiopaque fiducials permanently mark soft tissue for therapeutic procedures. APR 2 7 2012 {1}------------------------------------------------ The delivery system (i.e., needle, sheath, handle, and stylet) of EchoTip® Ultra Fiducial Needle is substantially equivalent to the EchoTip® Ultra Ultrasound Needle (510(k) No. K083330). Both are dimpled, endoscopic ultrasound needles that may be used to inject materials into tissues. The delivery system of the EchoTip® Ultra Fiducial Needle is a modified version of the EchoTip® Ultra Ultrasound Needle. Specifically, a laser cut track with notch has been added to the needle to secure the fiducials and a thumb ring has been added to the stylet hub to improve the ergonomics of fiducial deployment. ### Discussion of Tests and Test Results Cook conducted verification and validation testing establishing that design outputs met the design inputs. No toxicological concerns for pure gold implanted fiducials were identified by a Risk Assessment inclusive of exhaustive extraction under polar and non-polar conditions with accompanying chemical characterizations as well as the following biocompatibility tests: cytotoxicity, irritation sensitization and implantation. Additionally, simulated use demonstrated that the device could be used effectively without detachment or breakage, the fiducials were visible under ultrasound and common radiographic imaging techniques, and the fiducials are MR Conditional, as defined by ASTM F2503-08, Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment and the FDA guidance, Establishing Safety and Compatibility of Passive Implants in the Magnetic Resonance (MR) Environment. #### Conclusions Drawn from the Tests Outcomes from the evaluation of the EchoTip® Ultra Fiducial Needle provide evidence of its ability to mark soft tissues for future therapeutic procedures via endoscopic ultrasound placement and establish that it is substantially equivalent to the predicate devices in terms of intended use, biological safety and technological characteristics. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized human figure with outstretched arms, representing care and protection. The figure is positioned to the right of the department's name, which is arranged in a circular fashion around the logo. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". # DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002 APR 2 7 2012 Ms. Marge Walls-Walker Senior Regulatory Specialist: Engineering Wilson-Cook Medical, Inc. /Cook Endoscopy 4900 Bethania Station Road WINSTON-SALEM NC 27105 Re: K111895 Trade/Device Name: EchoTip® Ultra Fiducial Needle Regulation Number: 21 CFR 878.4300 Regulation Name: Implantable clip Regulatory Class: II Product Code: NEU and FCG Dated: April 19, 2012 Received: April 23, 2012 Dear Ms. Walls-Walker: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of {3}------------------------------------------------ medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely Yours, Janine M. Morris Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # INDICATIONS FOR USE 510(k) Number (if known): Device Name: EchoTip® Ultra Fiducial Needle Indications for Use: Intended to implant fiducials under endoscopic ultrasound to radiographically mark soft tissue for future therapeutic procedures. Prescription Use XX AND/OR Over-the-Counter Use (Per 21 CFR 801 Subpart D) (21 CRF 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) ## Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) (Division Sign-Off) Division of Radiologic Devices Office of In Vitro Diagnostic Device Evaluation and Safety 810K. K111895 Page 1 of --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/NEU/K111895](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/NEU/K111895) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com